STOCK TITAN

Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday August 19th, 2020

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Teligent, Inc. (NASDAQ: TLGT) will hold a conference call on August 19, 2020, at 8:00 AM ET to discuss their second-quarter financial results and provide a business update. Interested participants can join the call by calling (866) 393-8366 for domestic or (409) 350-3154 for international access. The call will also be available via webcast on Teligent's website in the Investor Relations section. Teligent aims to be a significant player in the specialty generic prescription drug market.

Positive
  • None.
Negative
  • None.

BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on Wednesday August 19th, 2020 to discuss the 2nd quarter 2020 financial results and business update.

The Company invites you to listen to the call by dialing (866) 393-8366.  International participants should call (409) 350-3154.  Participants should ask to join the Teligent, Inc. call.

This call is available via webcast and can be accessed under News & Events in the Investor Relations section of Teligent, Inc.'s website at www.teligent.com.

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

Contact:              
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com


FAQ

When is Teligent's Q2 2020 earnings call?

Teligent's Q2 2020 earnings call is scheduled for August 19, 2020, at 8:00 AM ET.

How can I listen to Teligent's earnings call?

You can listen to Teligent's earnings call by dialing (866) 393-8366 for domestic or (409) 350-3154 for international participants, or via webcast on their website.

What will Teligent discuss in their upcoming conference call?

Teligent will discuss their second-quarter financial results and provide a business update during the conference call.

What is Teligent's focus in the pharmaceutical market?

Teligent focuses on being a leading player in the specialty generic prescription drug market.

TLGT

NASDAQ:TLGT

TLGT Rankings

TLGT Latest News

TLGT Stock Data

92.77M
2.48%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Buena